Karius Inc. Quantitative Next-Generation Sequencing Testing

Notice of Intent to Award Sole Source to Karius, Inc.The Defense Health Agency, on behalf of Naval Medical Center, San Diego hereby publicizes its intention to solicit, negotiate, and award Commercial, Firm-Fixed-Price purchase order on a noncompetitive basis with Karius, Inc. The requirement is for the purchase of Quantitative Next-Generation Sequencing Testing.Based on the approved Justification and Approval (J&A), the agency has identified only one responsible source and no other supplier will satisfy agency requirements.A determination by the government NOT to compete based upon responses to this notice is solely at the discretion of the government. However, all responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency. The applicable NAICS Code is 621511 and the business size standard is $41.5Million.The point of contact for this announcement is Jessica Medina at Jessica.l.MatiasMedina.civ@health.mil.Be advised that the aforementioned information is anticipatory in nature and is not binding. A copy of the Request for Quote will be made available upon request. Any comments, questions or concerns regarding this notice may be submitted via e-mail to Jessica.l.MatiasMedina.civ@health.mil by 15 SEPTEMBER 2023 at 1600 PST. Questions by phone or fax will not be